Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis-an open-label study-Reference-Cited by-同舟云学术

Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis-an open-label study

Published:2017-12-04 Issue:3 Volume:30 Page:e13256
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterol Motil

Author:

Ashat M.¹,Lewis A.²,Liaquat H.³,Stocker A.³,McElmurray L.³,Vedanarayanan V.⁴,Soota K.¹,Howell T.⁵,Kedar A.⁶,Obert J.³,Abell T. L.⁷^ORCID

Affiliation:

1. Division of Gastroenterology, Hepatology & Nutrition; Department of Medicine; University of Iowa; Iowa City IA USA

2. Department of Internal Medicine; University of Louisville; Louisville KY USA

3. Division of Gastroenterology, Hepatology & Nutrition; Department of Medicine; University of Louisville; Louisville KY USA

4. Division of Neuromuscular Medicine; University of Mississippi; Oxford MS USA

5. GI Motility Clinic; Jewish Hospital; Louisville KY USA

6. Division of Medicine; University of Mississippi Medical Center; Jackson MS USA

7. Division of Gastroenterology, Hepatology & Nutrition; Department of Medicine; Jewish Hospital GI Motility Clinic; University of Louisville; Louisville KY USA

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nmo.13256/fullpdf

Reference56 articles.

1. Clinical guideline: management of gastroparesis;Camilleri;Am J Gastroenterol,2013

2. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?;Cutts;Neurogastroenterol Motil,2005

3. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004;Wang;Am J Gastroenterol,2008

4. Treatment of gastroparesis: a multidisciplinary clinical review;Abell;Neurogastroenterol Motil,2006

5. Electrophysiologic, morphologic, and serologic features of chronic unexplained nausea and vomiting: lessons learned from 121 consecutive patients;Abell;Surgery,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 update on the clinical management of gastroparesis;Expert Review of Gastroenterology & Hepatology;2023-03-29

2. Gastroparesis syndromes: emerging drug targets and potential therapeutic opportunities;Expert Opinion on Investigational Drugs;2023-03-04

3. Pathophysiology of Gastric Neuromuscular Disorders;The AFS Textbook of Foregut Disease;2023

4. Ten controversies in gastroparesis and a look to the future;Neurogastroenterology & Motility;2022-11-13

5. Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies;Journal of Clinical Medicine;2022-11-10